Aviceda Therapeutics Announces Formation of Executive Team
Posted on 553 Aviceda Therapeutics, a late-stage, pre-clinical biotech company focused on developing the next generation of immuno-modulators by harnessing the power of glycobiology to manipulate the innate immune system and chronic, non-resolving inflammation, is announcing the composition of the Executive Team that will guide the company through ongoing development of breakthrough, first-in-class therapeutics and continued growth opportunities as a business entity. Serving in key leadership roles on Aviceda’s Executive Leadersh...
Source: financialbuzz.com